|Articles|December 15, 2003

Injection application accepted by FDA

The FDA is weighing the application by Amphastar Pharmaceuticals Inc. for a hyaluronidase injection 150 units/ml, 1ml.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME